Taro Pharmaceutical Industries Balance Sheet Health
Financial Health criteria checks 6/6
Taro Pharmaceutical Industries has a total shareholder equity of $1.8B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $2.2B and $384.1M respectively. Taro Pharmaceutical Industries's EBIT is $35.2M making its interest coverage ratio -0.7. It has cash and short-term investments of $902.2M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -0.7x |
| Cash | US$902.22m |
| Equity | US$1.78b |
| Total liabilities | US$384.09m |
| Total assets | US$2.16b |
Recent financial health updates
Recent updates
Taro Pharmaceutical Industries Ltd. Is An Overlooked Opportunity
Dec 12Taro Pharmaceutical: Sun Pharma Deal Uncertain, No Discernible Value Beyond NAV (Rating Downgrade)
Aug 16Taro Pharmaceutical: Potential Value In Sun Pharma Offer
Jun 02Taro Pharmaceutical: Stagnating Growth At 1.6% Trailing Earnings Yield, Rate Hold
Feb 24Taro Pharmaceutical GAAP EPS of $0.19 misses by $0.68, revenue of $139.2M misses by $23.92M
Jan 24Taro Pharmaceutical Non-GAAP EPS of $0.66 misses by $0.18, revenue of $130.5M misses by $30.52M
Oct 28Taro Pharmaceutical hits 52-week low; down 28% YTD
Aug 15Taro Pharmaceutical Non-GAAP EPS of $1.09 beats by $0.24, revenue of $156.7M beats by $6.8M
Jul 27Taro Pharmaceutical: 10%+ Projected Earnings Yield Is A Strong Calling Card
Jul 14We Think Taro Pharmaceutical Industries' (NYSE:TARO) Healthy Earnings Might Be Conservative
Aug 03
A Look At Taro Pharmaceutical Industries' (NYSE:TARO) Share Price Returns
Jan 26
Financial Position Analysis
Short Term Liabilities: TARO's short term assets ($1.3B) exceed its short term liabilities ($374.1M).
Long Term Liabilities: TARO's short term assets ($1.3B) exceed its long term liabilities ($10.0M).
Debt to Equity History and Analysis
Debt Level: TARO is debt free.
Reducing Debt: TARO had no debt 5 years ago.
Debt Coverage: TARO has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: TARO has no debt, therefore coverage of interest payments is not a concern.